<DOC>
	<DOCNO>NCT02807597</DOCNO>
	<brief_summary>The investigator ' preclinical data demonstrate feasibility fluorescence-guided tumor resection Cancer Vision Goggles ( CVG ) LS301 animal model . In study , investigator conduct intraoperative imaging procedure minimal interference ongoing surgery . The underlying hypothesis accurate detection cancer cell highlight LS301 surgery reduce number breast cancer patient margin positivity le 5 % , compare current surgical paradigm great 20 % . The pilot study obtain critical data require address large question surgical margin assessment full Phase I clinical trial .</brief_summary>
	<brief_title>LS301 Uptake Tumors Patients Undergoing Partial Mastectomy Sentinel Lymph Node Biopsy Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Newly diagnose Stage III breast cancer patient undergo breastconserving therapy SLN biopsy . Negative nodal basin clinical exam . At least 18 year age . Able understand willing sign write informed consent document . Contraindications surgery . Receiving investigational agent . History allergic reaction attribute ICG agent use study , include know iodide seafood allergy . We expect many adverse reaction LS301 radioactive posse iodinate counterions . Pregnant . Female patient childbearing potential must negative serum urine pregnancy test 7 day start participation . Breastfeeding . Patients breastfeed exclude study unknown potential risk adverse event nurse infant secondary treatment mother LS301 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>